Prospective study on cervical neoplasia IV. Presence of HPV antibodies

International Journal of Cancer

Volumn 80, Issue 3, 1999, Pages 365-368

  Vonka, Vladimír ^a   Hamšíková, Eva ^a   Kaňka, Jirí ^b   Ludvíková, Viera ^a   Sapp, Martin ^c   Šmahel, Michal ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROCONVERSION; SEROPREVALENCE; UTERINE CERVIX TUMOR; VIRUS PARTICLE; WART VIRUS;

ADULT; ANTIBODIES, VIRAL; BIOLOGICAL MARKERS; DNA-BINDING PROTEINS; FEMALE; HUMANS; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 0344267646     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990129)80:3<365::AID-IJC5>3.0.CO;2-C     Document Type: Article

References (21)

1. ADAM, E., KAUFMAN, R.H., ADLER-STORTHZ, K., MELNICK, J.L. and DREESMAN, G.R.A., Prospective study of association of herpes simplex virus and human papillomavirus infection with cervical neoplasia in women exposed to diethylstilbestrol in utero. Int. J. Cancer, 35, 19-26 (1985).
2. CARTER, J.J., KOUTSKY, L.A., WIPF, G.C., CHRISTENSEN, N.D., LEE, S.K., KUYPERS, J., KIVIAT, N. and GALLOWAY, D.A., The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women. J. infect. Dis., 174, 927-936 (1996).
3. DE GRUIJL, T.D., BONTKES, H.J., WALBOOMERS, J.M.M., SCHILLER, J.T., STUKART, M.J., GROOT, B.S., CHABALD, M.M.R., REMMINK, A.J., VERHEIJEN, R.H.M., HELMERHORST, T.J.M., MEIJER, C.J.L.M. and SCHEPER, R.J., Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia. J. nat. Cancer Inst., 89, 630-638 (1997).
4. DE SANJOSE, S. and 14 OTHERS, Serological response to HPV16 in CIN III and cervical cancer patients. Case-control studies in Spain and Colombia. Int. J. Cancer, 66, 70-74 (1996).
5. DILLNER, J., Antibody responses to defined HPV epitopes in cervical neoplasia. Papillomavirus Rep., 5, 35-41 (1994).
6. DILLNER, J. and 14 OTHERS, Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer. J. nat. Cancer Inst., 89, 1293-1299 (1997).
7. ELFGREN, K., BISTOLETTI, P., DILLNER, L., WALBOOMERS, J.M., MEIJER, C.J. and DILLNER, J., Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens. Amer. J Obstetr. Gynecol., 174, 937-942 (1996).
8. GALLOWAY, D.A., Papillomavirus capsids: a new approach to identify serological markers of HPV infection. J. nat. Cancer Inst., 86, 474-475 (1994).
9. HAMŠÍKOVÁ, E., NOVÁK, J., HOFMANNOVÁ, V., MUÑOZ, N., BOSCH, F.X., DE SANJOSE, S., SHAH, K., ROTH, Z. and VONKA, V., Presence of antibodies to seven human papillomavirus type 16-derived peptides in cervical cancer patients and healthy controls. J. infect. Dis., 170, 1424-1431 (1994).
10. HAMŠÍKOVÁ, E., ŠMAHEL, M., SAPP, M., MUÑOZ, N., BOSCH, F.X., SHAH, K.V. and VONKA, V., Correlation between the presence of anti HPV33 VLP antibodies and HPV DNA in cervical neoplasia patients. Arch. Virol., 142, 413-416 (1997).
11. HO, G.Y., BURK, R.D., KLEIN, S., KADISH, A.S., CHANG, C.J., PALAN, P., BASU, J., TACHEZY, R., LEWIS, R. and ROMNEY, S., Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J. nat. Cancer Inst., 87, 1365-1371 (1995).
12. KIRNBAUER, R., HUBBERT, N.L., WHEELER, C.M., BECKER, T.M., LOWY, D.R. and SCHILLER, J.T., A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J. nat. Cancer Inst., 86, 494-499 (1994).
13. KRČMÁŘ, M., SUCHÁNKOVÁ, A., KAŇKA, J. and VONKA, V., Prospective study on the relationship between cervical neoplasia and herpes simplex 2 virus. III. Presence of herpes simplex type 2 antibody in sera of subjects who developed cervical neoplasia later in the study. Int. J. Cancer, 38, 161-165 (1986).
14. LEHTINEN, M., DILLNER, J., KNEKT, P., LUOSTARINEN, T., AROMAA, A., KIRNBAUER, R., KOSKELA, P., PAAVONEN, J., PETO, R., SCHILLER, J.T. and HAKAMA, M., Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study. Brit. med. J., 312, 537-539 (1996).
15. LEHTINEN, M., HAKAMA, M., AARAN, R.-K., AROMAA, A., KNEKT, P., LEINIKKI, P., MAATELA, J., PETO, R. and TEPPO, L., Herpes simplex virus type 2 infection and cervical cancer: a prospective study of 12 years follow-up in Finland. Cancer Causes Control, 3, 333-338 (1993).
16. MUŇOZ, N. and 17 OTHERS, The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int. J. Cancer, 52, 743-749 (1992).
17. SASAGAWA, T., YAMAZAKI, H., DONG, YU, Z., SATAKE, S.-I., TATENO, M. and INOUE, M., Immunoglobulin-A and -G responses against virus-like particles (VLP) of human papillomavirus type 16 in women with cervical cancer and cervical intra-epithelial lesions. Int. J. Cancer, 75, 529-535 (1998).
18. VILADIU, P. and 17 OTHERS, Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer. J. clin. Oncol., 15, 610-619 (1997).
19. VONKA, V. and 12 OTHERS, Prospective study on the relationship between cervical neoplasia and herpes simplex type-2 virus. II. Herpes simplex type-2 antibody presence in sera taken at enrollment. Int. J. Cancer, 33, 61-66 (1984a).
20. VONKA, V. and 13 OTHERS, Prospective study on the relationship between cervical neoplasia and herpes simplex type-2 virus. I. Epidemiological characteristics. Int. J. Cancer, 33, 49-60 (1984b).
21. ZUR HAUSEN, H., Papillomavirus infections - a major cause of human cancers. Biochim. biophys. Acta, 1288, F55-F78 (1996).